---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-037976"
form_type: "8-K"
ticker: null
cik: "0000786947"
company_name: "ACURA PHARMACEUTICALS, INC"
filed_at: "2025-04-23T23:59:59+00:00"
generated_at: "2026-05-23T08:37:59.681695+00:00"
event_type: "debt"
sentiment: "negative"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# Acura receives $200K in new loans from controlling shareholder; debt due May 31, warns of possible bankruptcy

## Summary
- Secured note principal now $7,794,279 with ~$650,000 accrued interest; 5.25% interest rate, due May 31, 2025.
- New $100,000 loans from controlling shareholder AD Pharma on April 4 and April 18, 2025; AD Pharma owns ~65% of Acura common stock.
- If not paid by May 31, 2025, overdue amounts bear default interest at 7.5% per annum.
- Without additional financing by mid-May 2025, Acura warns it may scale back operations, furlough employees, or seek bankruptcy; total loss of shareholder value possible.

## SEC filing metadata
- accession: 0001104659-25-037976
- form_type: 8-K
- cik: 0000786947
- company_name: ACURA PHARMACEUTICALS, INC
- filed_at: 2025-04-23T23:59:59+00:00
- event_type: debt
- sentiment: negative
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 1.01, 2.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/786947/000110465925037976/0001104659-25-037976-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/786947/000110465925037976/tm2513007d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-037976
- JSON: https://secwatch.observer/filing/0001104659-25-037976.json
- Plain text: https://secwatch.observer/filing/0001104659-25-037976.txt

## Key facts
- Debt Financings
  ACURA PHARMACEUTICALS, INC incurred loan of loans of $100,000 with Abuse Deterrent Pharma, LLC at 5.25% maturing May 31, 2025.
  - Instrument: loan
  - Principal: loans of $100,000
  - Counterparty: Abuse Deterrent Pharma, LLC
  - Rate: 5.25%
  - Maturity: May 31, 2025
  - Event: incurrence
  source text: On each of April 4, 2025 and April 18, 2025 we received loans of $100,000 from Abuse Deterrent Pharma, LLC ("AD Pharma").
  evidence_url: https://www.sec.gov/Archives/edgar/data/786947/000110465925037976/0001104659-25-037976-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.